Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings

Shyh Dar Shyur, Ren Long Jan, James R. Webster, Ping Chang, Yu Jung Lu, Jiu-Yao Wang

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Our aims were to evaluate the performance of an automated microfluidic immunoassay system for measuring allergen-specific IgE (sIgE) in sera against an established in vitro assay and to assess the system's diagnostic accuracy against objective clinical criteria for identifying sensitization to specific allergens in daily practice of allergy clinics. Using both the automated microfluidic-based immunoassay system (BioIC®) and ImmunoCAP ®, we measured sIgE in serum samples from 212 children who visited allergic clinics in two medical centers. Outcomes of skin prick tests (SPT) served as the clinical comparison method. The assay results of targeted allergen of BioIC have a good correlation with ImmunoCAP in the diagnosis of allergen sensitivity by patients' clinical history. When comparing the test results of the sIgE against overall allergens, in either two tests among the three assays performed showed high percentage of agreement between BioIC and ImmunoCAP (77.8%, 95% CI: 72-83.3%) but not with SPT (BioIC 64.9%, 95% CI: 58-72%; ImmunoCAP 67.5%, 95% CI: 61-74%). Using ROC analysis and SPT as quasi-standard, BioIC and ImmunoCAP have nearly the same performance of sensitivity and specificity in the confirmation of SPT results. The total and within one-class agreements of each allergen test result between BioIC and ImmunoCAP ranged between 55.2% and 99.5% with an overall average of 80.9%. Laboratory testing for sIgE can be performed on a fully automated, microfluidic cartridge system with advantages of low sample volume, simultaneously tested allergens, and with diagnostic accuracy for representative allergens equivalent to the semi-automated CAP technology.

Original languageEnglish
Pages (from-to)623-633
Number of pages11
JournalPediatric Allergy and Immunology
Volume21
Issue number4 PART 1
DOIs
Publication statusPublished - 2010 Jun 1

Fingerprint

Microfluidics
Immunoassay
Allergens
Immunoglobulin E
Skin Tests
Serum
ROC Curve
Hypersensitivity
Technology
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Immunology

Cite this

Shyur, Shyh Dar ; Jan, Ren Long ; Webster, James R. ; Chang, Ping ; Lu, Yu Jung ; Wang, Jiu-Yao. / Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings. In: Pediatric Allergy and Immunology. 2010 ; Vol. 21, No. 4 PART 1. pp. 623-633.
@article{82fc5644599d48b6838d0ea8194ba392,
title = "Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings",
abstract = "Our aims were to evaluate the performance of an automated microfluidic immunoassay system for measuring allergen-specific IgE (sIgE) in sera against an established in vitro assay and to assess the system's diagnostic accuracy against objective clinical criteria for identifying sensitization to specific allergens in daily practice of allergy clinics. Using both the automated microfluidic-based immunoassay system (BioIC{\circledR}) and ImmunoCAP {\circledR}, we measured sIgE in serum samples from 212 children who visited allergic clinics in two medical centers. Outcomes of skin prick tests (SPT) served as the clinical comparison method. The assay results of targeted allergen of BioIC have a good correlation with ImmunoCAP in the diagnosis of allergen sensitivity by patients' clinical history. When comparing the test results of the sIgE against overall allergens, in either two tests among the three assays performed showed high percentage of agreement between BioIC and ImmunoCAP (77.8{\%}, 95{\%} CI: 72-83.3{\%}) but not with SPT (BioIC 64.9{\%}, 95{\%} CI: 58-72{\%}; ImmunoCAP 67.5{\%}, 95{\%} CI: 61-74{\%}). Using ROC analysis and SPT as quasi-standard, BioIC and ImmunoCAP have nearly the same performance of sensitivity and specificity in the confirmation of SPT results. The total and within one-class agreements of each allergen test result between BioIC and ImmunoCAP ranged between 55.2{\%} and 99.5{\%} with an overall average of 80.9{\%}. Laboratory testing for sIgE can be performed on a fully automated, microfluidic cartridge system with advantages of low sample volume, simultaneously tested allergens, and with diagnostic accuracy for representative allergens equivalent to the semi-automated CAP technology.",
author = "Shyur, {Shyh Dar} and Jan, {Ren Long} and Webster, {James R.} and Ping Chang and Lu, {Yu Jung} and Jiu-Yao Wang",
year = "2010",
month = "6",
day = "1",
doi = "10.1111/j.1399-3038.2009.00956.x",
language = "English",
volume = "21",
pages = "623--633",
journal = "Pediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",
number = "4 PART 1",

}

Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings. / Shyur, Shyh Dar; Jan, Ren Long; Webster, James R.; Chang, Ping; Lu, Yu Jung; Wang, Jiu-Yao.

In: Pediatric Allergy and Immunology, Vol. 21, No. 4 PART 1, 01.06.2010, p. 623-633.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings

AU - Shyur, Shyh Dar

AU - Jan, Ren Long

AU - Webster, James R.

AU - Chang, Ping

AU - Lu, Yu Jung

AU - Wang, Jiu-Yao

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Our aims were to evaluate the performance of an automated microfluidic immunoassay system for measuring allergen-specific IgE (sIgE) in sera against an established in vitro assay and to assess the system's diagnostic accuracy against objective clinical criteria for identifying sensitization to specific allergens in daily practice of allergy clinics. Using both the automated microfluidic-based immunoassay system (BioIC®) and ImmunoCAP ®, we measured sIgE in serum samples from 212 children who visited allergic clinics in two medical centers. Outcomes of skin prick tests (SPT) served as the clinical comparison method. The assay results of targeted allergen of BioIC have a good correlation with ImmunoCAP in the diagnosis of allergen sensitivity by patients' clinical history. When comparing the test results of the sIgE against overall allergens, in either two tests among the three assays performed showed high percentage of agreement between BioIC and ImmunoCAP (77.8%, 95% CI: 72-83.3%) but not with SPT (BioIC 64.9%, 95% CI: 58-72%; ImmunoCAP 67.5%, 95% CI: 61-74%). Using ROC analysis and SPT as quasi-standard, BioIC and ImmunoCAP have nearly the same performance of sensitivity and specificity in the confirmation of SPT results. The total and within one-class agreements of each allergen test result between BioIC and ImmunoCAP ranged between 55.2% and 99.5% with an overall average of 80.9%. Laboratory testing for sIgE can be performed on a fully automated, microfluidic cartridge system with advantages of low sample volume, simultaneously tested allergens, and with diagnostic accuracy for representative allergens equivalent to the semi-automated CAP technology.

AB - Our aims were to evaluate the performance of an automated microfluidic immunoassay system for measuring allergen-specific IgE (sIgE) in sera against an established in vitro assay and to assess the system's diagnostic accuracy against objective clinical criteria for identifying sensitization to specific allergens in daily practice of allergy clinics. Using both the automated microfluidic-based immunoassay system (BioIC®) and ImmunoCAP ®, we measured sIgE in serum samples from 212 children who visited allergic clinics in two medical centers. Outcomes of skin prick tests (SPT) served as the clinical comparison method. The assay results of targeted allergen of BioIC have a good correlation with ImmunoCAP in the diagnosis of allergen sensitivity by patients' clinical history. When comparing the test results of the sIgE against overall allergens, in either two tests among the three assays performed showed high percentage of agreement between BioIC and ImmunoCAP (77.8%, 95% CI: 72-83.3%) but not with SPT (BioIC 64.9%, 95% CI: 58-72%; ImmunoCAP 67.5%, 95% CI: 61-74%). Using ROC analysis and SPT as quasi-standard, BioIC and ImmunoCAP have nearly the same performance of sensitivity and specificity in the confirmation of SPT results. The total and within one-class agreements of each allergen test result between BioIC and ImmunoCAP ranged between 55.2% and 99.5% with an overall average of 80.9%. Laboratory testing for sIgE can be performed on a fully automated, microfluidic cartridge system with advantages of low sample volume, simultaneously tested allergens, and with diagnostic accuracy for representative allergens equivalent to the semi-automated CAP technology.

UR - http://www.scopus.com/inward/record.url?scp=77953316707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953316707&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3038.2009.00956.x

DO - 10.1111/j.1399-3038.2009.00956.x

M3 - Article

VL - 21

SP - 623

EP - 633

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

SN - 0905-6157

IS - 4 PART 1

ER -